Kentaro Wakasa
Obihiro, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.
Journal: International journal of hematology
Published: February 24, 2026
Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.
Journal: Hematology (Amsterdam, Netherlands)
Published: February 10, 2026
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.
Journal: Haematologica
Published: December 09, 2023
Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study.
Journal: British journal of haematology
Published: November 10, 2023
Pernicious Anemia in an Adult with Trisomy 21.
Journal: Case reports in immunology
Published: June 27, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
Journal: European journal of haematology
Published: April 30, 2023
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis.
Journal: British journal of haematology
Published: February 16, 2023
Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study.
Journal: International journal of hematology
Published: November 24, 2022
Pretreatment evaluation of fluorescence resonance energy transfer-based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib.
Journal: Cancer science
Published: February 07, 2018
Last Updated: 09/26/2026